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ABSTRACT 
Objective: Rifampicin (RIF) could be a recognized therapeutic and preventive agent against tuberculosis. Still, high rates of many side effects and 
symptoms related to hepatotoxicity have identified during treatment. So, the current study was aimed to evaluate the antioxidant and hepatoprotective 
activity of methanolic extract of Annona Squamosa Linn (MEAS) and N-Acetyl Cysteine (NAC) against RIF induced hepatic injury in male rats.  
Methods: The hepatoprotective effects of MEAS (500 mg/kg b.wt.) and NAC (100 mg/kg b.wt.) or co-treatment were assessed in a model of 
hepatotoxicity by RIF (300 mg/kg b. wt.) in male rats daily for 21 d. Moreover, bilirubin, total protein, albumin, ALT, AST, ALP, GGT, MDA, and GSH 
were estimated. In addition, the levels of IL-6, IL-10, 8(OH)dG, and Bcl2 were evaluated.  
Results: The oral administration of MEAS and NAC or their combination resulted in significant reductions in the levels of bilirubin, albumin, hepato-
specific markers namely ALT, AST, ALP, GGT, and MDA as compared to the RIF group. Furthermore, MEAS and NAC or the combination of MEAS and 
NAC treatment significantly up-regulated the levels of total protein, glutathione reductase with concomitant decrease in inflammatory marker level 
IL-6 and apoptotic marker level 8(OH)dG as well as increment the level of anti-inflammatory marker IL-10 and anti-apoptotic marker Bcl2 as 
compared to the RIF group. Histological examination of the liver tissue indicated that co-treatment with MEAS and NAC completely abolished the 
inflammation and degeneration in hepatocytes and restore the liver tissue to its normal structure. 
Conclusion: The present findings demonstrated that a co-treatment of MEAS and NAC seems to be more productive and curative than alone MEAS 
or NAC treatment and strongly compensated the liver damage induced by RIF.  
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INTRODUCTION 
Tuberculosis (TB) remains one of the fatal infectious diseases 
triggered by bacillus mycobacteria, mainly Mycobacterium 
tuberculosis. It proceeds to be a major global health problem, 
responsible for ill-health among millions of people each year. 
Concurring to the World Health Organization (WHO), in 2010, 8.8 
million people go to be ill with TB, and 1.45 million died, mainly in 
developing countries [1]. TB positions being as the second leading 
reason for death from an infective disease worldwide, after the 
human immunodeficiency infection [2]. The foremost efficient first-
line anti-TB drug, rifampicin, come to be available in 1960 [3]. 
However, drug-induced hepatotoxicity continues to be a great 
problem in the management of TB [4]. It is the main cause of 
disruption during a tuberculosis treatment course and may lead to 
hospitalization or life-threatening events [3, 5]. It is reported to be 
mediated through oxidative stress, which leads to lipid peroxidation 
and an alteration in antioxidant levels in the body. It has been 
recognized that oxidative stress remains one of the mechanisms for 
Isoniazid (INZ) and RIF initiated hepatic injury [6]. But, reactive 
oxygen species (ROS) strengthened RIF-INZ-induced hepatotoxicity, 
cardiovascular diseases, cancer, inflammatory diseases, autoimmune 
diseases (diabetes), neurodegenerative diseases, and aging decline [7]. 
Therapeutic drugs from natural products are still promising trends 
in the modulation of liver toxicity associated with antituberculous 
drug (ATD) treatment. Consequently, numerous traditional cures 
from plant origin are tested for its possible antioxidant and 
hepatoprotective liver damage in the investigational animal model 
[8]. Annona squamosa Linn (AS) is a multiuse tree with appetizing 
fruits and medicinal properties. Massive biological research has 
been conducted on this plant because of the presence of valuable 
annonaceous acetogenins in various parts of the plant leaves, bark, 
stems, and seedcake [9]. It is confirmed to have antioxidant 
properties, free radical scavenging action, hypoglycemic and 
antidiabetic activity [10]. Numerous bioactive components like 
acetogenin, flavonoids, aporphine alkaloids, glycoside, and 
squamoline were isolated from the bark and leaves of this plant [11]. 
Among the possible antioxidant chemicals, N-acetyl Cysteine (NAC) 
known to be utilized within the treatment of various disorders [12]. 
Moreover, it was demonstrated that NAC, a thiol-containing 
antioxidant, acts as a direct scavenger of free radicals and a 
precursor for GSH biosynthesis [13, 14]. It can inhibit the induction 
of pro-inflammatory cytokines and can also block the tumor necrosis 
factor-α (TNF-α)-induced apoptotic cell death [15]. It appears that 
NAC supplementation increases glutathione and plays an important 
role in the neutralization of toxic substances and has a strong 
protective effect on the cells [16]. 
So, the current study was designed to evaluate the antioxidant and 
hepatoprotective activity of MEAS extract and NAC against RIF induced 
hepatic injury in male rats in order to understand the mechanisms by 
which the MEAS reduce the risk of hepatotoxicity occurrence. 
MATERIALS AND METHODS 
Chemicals and drugs 
RIF as (Rimactane) was purchased from Future Pharmaceutical 
Industries, Egypt. Each capsule contains 300 mg of the active 
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ingredient rifampicin. NAC was purchased from Sigma-Aldrich Co., 
(St. Louis, MO, USA). All the other reagents, solvents, and chemicals 
used for analysis convened the quality criteria in accord with the 
International Standards. 
Collection of plant material 
The leaves of AS were collected in April 2018 from the Botanical 
Garden of the Faculty of Science, Ain Shams University, Egypt. The 
plant material was identified and the specimen was deposited at the 
Herbarium, Department of Botany, National Research Centre, Cairo, 
Egypt, for reference (voucher no. 521). After identification, the plant 
substance was processed for the extraction process. 
Preparation of the plant extract 
The leaves of AS were carefully cleaned with water to eradicate dust 
particles and shade-dry out at room temperature and the shade dried 
leaves were crushed to get course particles. Just About 200 g of dry 
powder was extracted with methanol by constant hot percolation, 
using soxhlet apparatus. The resulted dark brown extract was 
concentrated up to 100 ml on rota vapor under lowered pressure. The 
concentrated crude extract (50 g) was lyophilized into powder and 
stored in the refrigerator (-40 C) until further than use [11]. 
Animals 
Adult male albino rats weighting (120–140 g) were obtained from 
the animal house of the National Research Center (NRC, Giza, Egypt). 
The rats were housed in the air-conditioned atmosphere, at a 
temperature of 25 °C, relative air humidity (40–60%) with 
alternatively 12 h light and dark cycles. The animals were acclimated 
for two weeks before experimentation. Animals were nourished 
with standard laboratory rat diet and water provided ad libitum. 
Animal procedures were performed in accordance with the 
declaration of Helsinki and the guidelines for the care and use of 
experimental animals established by the Committee for Control and 
Supervision of Experiments on Animals (CPCSEA) and the National 
Institutes of Health (NIH) protocol (registration number: 13/165). 
Experimental design 
A total of 50 adult male albino rats of Wistar strain weighing 
120±20g were divided into five equal groups (n=10) with the 
following treatments: Group 1(con): left without treatment served as 
control. Group 2(RIF): Rats were orally administrated with RIF (300 
mg/kg b. wt.) once daily for 21 d, according to Lian et al. [17]. Group 
3 (RIF+MEAS): Rats were orally administrated with RIF(300 mg/kg 
b. wt.) and then treated orally with MEAS (500 mg/kg b. wt.) once 
daily for 21 d according to Uduma et al. [11]. Group 4 (RIF+NAC): 
Rats were orally administrated with RIF(300 mg/kg b. wt.) and then 
treated orally with NAC (100 mg/kg b. wt.), once daily for 21 d 
according to Rana et al. [18]. Group 5 (RIF+MEAS+NAC): Rats were 
orally administrated with RIF(300 mg/kg b. wt.) and then treated 
orally with MEAS (500 mg/kg b. wt.) and NAC(100 mg/kg b. wt.) 
once daily for 21 d. At the end of the experiments (day 22), animals 
were slaughtered to get tissue samples. 
Samples collection 
At the end of the experiment, all animals were sacrificed. Blood 
samples were collected and serum samples were obtained in clean 
and dry test tubes; by leaving to clot for 15 min and then centrifuged 
at 3000 rpm for 20 min and kept at-20 °C until further analysis. Also, 
tissue samples from the liver were dissected.  
Biochemical assays 
Serum total bilirubin was determined by a colorimetric method as 
described by Kaplan et al. [19] using a diagnostic kit supplied by 
Biodiagnostic Company (Giza, Egypt). The serum total protein level 
was determined by the colorimetric method of Lowry et al. [20]. 
Serum albumin was determined by the colorimetric method using 
the Biodiagnostic kit (Egypt) following the method of Doumas and 
Biggs [21]. Serum alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) activity were evaluated colorimetrically 
using a kit purchased from BioMed Diagnostics Company (Egypt) as 
maintained by Tietz [22]. Serum alkaline phosphatase (ALP) level 
was determined colorimetrically according to Belfield and Goldberg 
[23] using a commercial a kit supplied by Diamond Diagnostic 
Company (Giza, Egypt). Hepatic gamma Glutamyl transferase (GGT) 
level was determined by the method of Szasz and Persijn [24] using 
a kit supplied by the Egyptian company for Biotechnology (Egypt). 
Hepatic MDA content was determined by a colorimetric method 
using the Biodiagnostic kit (Egypt) following the method of Ohkawa 
et al. [25]. The activity of glutathione reductase (GSH) level in liver 
tissue was performed according to the method of Beutler et al. [26]. 
The level of interleukin-6 (IL-6) was assayed in the liver 
homogenate with ELISA technique, according to Boulanger et al. [27] 
using a kit supplied by MyBioSource Company (San Diego, CA, USA). 
Hepatic level of interleukin-10 (IL-10) was determined with ELISA 
technique according to the method of Eskdale et al. [28] using a kit 
obtained from MyBioSource Inc. (San Diego, CA, USA). The activity of 
hepatic 8-hydroxy-2'-deoxyguanosine (8-OHdG) was carried out by 
the ELISA technique using a kit purchased from CUSABIO Co., (San 
Diego, CA, USA), according to manufacturer’s instructions. Liver Bcl2 
content was measured by the ELISA technique using a kit purchased 
from MyBioSource (San Diego, CA, USA) according to the 
manufacturer’s instructions. 
Histopathological examination  
Liver tissue samples were cut out and washed with normal saline, 
then fixed in 10% formalin and stained with hematoxylin and eosin 
stains for histopathological examination, according to Banchroft et 
al. [29]. Afterward, staining, the slides were viewed under a 
microscope for degeneration, necrotic changes, and evidence of 
hepatotoxicity. 
Statistical analysis 
Results are expressed as mean±S. E of the mean for the ten rats in 
each group. Statistical Package for the Social Sciences program 
(SPSS), version 14.0, USA was used to compare significance between 
every two groups. The difference was considered statistically 
significant at p ≤ 0.05. Percentage difference representing the 
percent of variation for the corresponding control group was 
calculated according to the subsequent formula:  
 
RESULTS 
Effects of treatment with RIF, MEAS, and NAC on liver functions 
in male rats 
The data in table (1) illustrated the effect of RIF, MEAS, and NAC or 
both on liver functions of male rats. A significant increase (p<0.001) 
in serum bilirubin, ALT, AST, ALP and GGT levels recorded 
(582.76%, 212.69%, 82.59%, 100.98% and 319.77%, respectively) 
was detected in RIF group versus the control group. These recorded 
increases were significantly improved in the MEAS, NAC and 
MEAS+NAC groups. However, total serum protein and albumin 
levels recorded the marked depletion (p<0.01) in the RIF group (-
40.39% and-47.76% individually) versus the control group. In 
contrast, a considerable increment in serum total protein and 
albumin levels was demonstrated (p<0.01) in the RIF group, which 
received MEAS (52.89% and 70.48% separately) and MEAS+NAC 
(59.50% and 84.76% separately) versus RIF group. 
Effects of treatment with RIF, MEAS, and NAC on hepatic 
oxidative stress markers in male rats 
The result of this study indicated that a recognized increase 
(P<0.001) in the hepatic MDA level (116.31%) correlated with a 
decline in the GSH level (-58.90%) in RIF treated group contrary 
to control group (table 2). On the other hand, treatment of RIF 
group with MEAS, NAC or their combination resulted in 
significant decreases (P<0.01) in MDA levels (-42.04%,-48.69% 
and-55.60%, separately) and significant increment in the activity 
of GSH (76.11%, 97.79%, and 115.93%, individually) versus to 
Rif group. 
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Table 1: Effects of treatment with RIF, MEAS, and NAC on liver functions in male rats 
 Groups 
parameters 
Con RIF RIF+MEAS RIF+NAC RIF+MEAS+NAC 
Bilirubin 
(mg/dl) 




















































(Means±SE, n=10); * indicates P<0.05;** indicates P<0.01; *** indicates P<0.001, a: % of change from the normal control group; b: % of change from 
the RIF group. 
 
Table 2: Effects of treatment with RIF, MEAS and NAC on oxidative stress markers in male rats 
 Groups 
parameters 





















(Means±SE, n=10); * indicates P<0.05;** indicates P<0.01; *** indicates P<0.001, a: % of change from the normal control group; b: % of change from 
the RIF group. 
 
Effects of treatment with RIF, MEAS, and NAC on inflammatory 
markers in male rats 
The findings represented in table 3 exhibited the effect of MEAS, NAC, 
and their combination treatment on the inflammatory mediator's levels 
of RIF treated rats. The results showed that the levels of IL-6 Production 
dramatically increased (411.99%) after RIF treatment. In contrast, RIF-
induced IL-6 production was dose-dependently suppressed by 
administration of MEAS, NAC, and MEAS+NAC recorded (-39.00%,-
55.21% and-56.07%, individually) when compared with the RIF group. 
Meanwhile, RIF administration decreased significantly (P<0.001) the 
level of IL-10 as compared to the control group. On the other hand, 
increased levels of IL-10 were recorded following the treatment of the 
RIF group with MEAS, NAC, or MEAS+NAC compared to the RIF group. 
 
Table 3: Effects of treatment with RIF, MEAS, and NAC on inflammatory and anti-inflammatory markers in male rats 
Groups 
parameters 

















(Means±SE, n=10); * indicates P<0.05;** indicates P<0.01; *** indicates P<0.001, a: % of change from the normal control group; b: % of change from 
the Rif group. 
 
Effects of treatment with RIF, MEAS, and NAC on apoptotic 
markers in male rats 
As shown in table 4, administration of RIF significantly (P<0.001) 
upregulation the level of 8-(OH)dG (298.95%), indicating acceleration 
of apoptosis manifested by significant (P<0.01) downregulation in the 
level of Bcl2 (-62.87%) contrary to the control group. However, 
treatment of Rif group with MEAS or MEAS and NAC significantly 
improved the levels of 8-(OH)dG and Bcl2 near to normal levels 
compared to both of Rif and control groups (table 4). 
 
Table 4: Effects of treatment with RIF, MEAS, and NAC on apoptotic and anti-apoptotic markers in male rats 
Groups 
parameters 





















(Means±SE, n=10); * indicates P<0.05;** indicates P<0.01; *** indicates P<0.001, a: % of change from the normal control group; b: % of change from 
the RIF group. 
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Histopathological investigation 
The liver tissue of healthful control rats showed an abundant central 
vein surrounded by an anastomose network of healthy hepatocytes 
and blood sinusoids in between (fig. 1A). But the administration of 
RIF caused marked damage in the liver as evident by dilatation of 
portal veins, scattering of a great amount of inflammatory cells, 
necrotic lesions, and degeneration of hepatocytes (fig. 1B, C). On the 
other hand, treatment with NAC revealed some changes in the liver 
tissue demonstrated by the degeneration of liver cells with necrotic 
foci (fig. 1B, D). Moreover, numerous scattered inflammatory 
infiltrative cells appeared in the tissue besides to dilatation in portal 
vein was noted in rats treated with MEAS (fig. 1E). However, The co-
treatment with MEAS+NAC showed great improvement in the liver 
tissue evidenced by the appearance of healthy hepatocytes arranged 
to some extent normal architecture (fig. 1F). 
 
 
Fig. 1: Histopathological analysis of liver tissue of control rats and different studied groups (H and E X 400). (A) Photomicrographs of liver 
sections of control showing normal hepatocytes (H) arranged around a central vein (CV) and separated by hepatic sinusoid (HS) 
containing kupffer cell (arrows). (B, C) hepatic Section of RIF treated rats displayed thickened dilated and congested portal vein (arrow) 
surrounded by scattered leucocytic inflammatory cell (head arrow), disorganized hepatic strands with dilated blood sinusoid (arrow), 
pyknosis (head arrow) and necrotic foci (*). (D) Liver Section of rats treated with NAC showing relatively healthy liver tissue with 
necrotic foci (arrow) and activation of kupffer cells (head arrow). (E) Liver section of rats treated with MEAS showing inflammatory cells 
(arrow) and vacuolar degeneration (head arrow). (F) The hepatic section of rats treated with MEAS and NAC showing the almost normal 
hepatic structure and central vein (CV) 
 
DISCUSSION 
The liver is an important organ that regulates numerous 
physiological processes. It contributes to the synthesis of vital 
molecules such as albumin, fibrinogen, cholesterol, and bile acid. It is 
a source of enzymes capable of transforming foreign molecules. As a 
result, it metabolizes and detoxifies various endogenous and 
exogenous compounds [30]. In view of this idea, the present study 
showed that rats treated with anti-tubercular drug RIF recorded a 
dose-dependent, significant (p<0.05) elevation in liver biomarkers 
enzymes as bilirubin, ALT, AST, ALP and GGT levels accompanied by 
decreases in the levels of total protein and total albumin when 
compared with the normal control group. These results may be due 
to a consequence of hepatic damage occur by RIF [31, 32]. The 
reduction in total protein and total albumin levels indicates that Rif 
administration caused an impairment of liver function through 
decreases the capacity of the liver to synthesis albumin from the 
hepatic parenchyma [33]. Also, the increase in serum bilirubin 
indicates to hepatobiliary disease and severe disturbance of 
hepatocellular function [34]. Furthermore, the present findings are 
also, consistent with Saraswathy et al. [35] who attributed the 
decrease in total protein level to the biotransformation of RIF into its 
active metabolism, 25-desacetyl rifampicin which reduced the drug-
metabolizing enzymes and specifically binds to RNA polymerase 
which inhibits the nucleic acid and protein synthesis responsible for 
hepatotoxicity. Moreover, the disaggregation of polyribosomal 
profiles induced by antituberculosis drugs is also associated with the 
inhibition of protein synthesis, which may be parallelly responsible 
for the fatty liver, although it contributes to disabling of the cell [36]. 
The elevations in the levels of ALP and GGT in the present work may 
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administration. Whereas ALP is mainly excreted by the liver in the 
cytoplasm of hepatocytes and the synthesis of ALP is increased when 
the liver cells are damaged, which leads to the increase of its level in 
the blood [37]. Moreover, GGT is considered one of the best indicators 
of liver damage, whereas it is embedded in the hepatocytes plasma 
membrane in the canalicular domain, and its liberation into serum 
indicates damage of the cells [38]. Interestingly, it has been reported 
that, in cases of liver damage with hepatocellular lesions and 
parenchymal cell necrosis, the liver marker enzymes are released from 
the damaged tissues into the bloodstream [39]. 
The results of the present study demonstrated that the co-
administration of MEAS and NAC reduced significantly the toxic 
effects induced by RIF in the liver via decreasing the 
histopathological changes in the liver tissue and inhibiting the 
leakage of liver aminotransferases and ALP into the blood. 
Compatible with the present results, other studies reported that 
treatment with MEAS and NAC induced a significant decrease in 
serum ALT, AST, ALP and GGT activities reflected by increases in the 
levels of serum bilirubin, serum total protein and albumin in rats 
treated with the RIF in combination with other anti-tuberculosis 
drugs [40, 41]. In addition, the reduction is shown in the present 
study in the bilirubin levels and GGT activity in the RIF group treated 
with combined doses of MEAS and NAC probably proved their 
hepatoprotective and antioxidative effects. 
It has been recognized that a high level of ROS may cause uncontrolled 
oxidative stress (Imbalance of prooxidants and antioxidants towards 
prooxidants) [42]. Furthermore, the alteration in lipid outline is the main 
factor for excessive lipid peroxidation and oxidative stress that resulted 
from the increase in ROS production and a reduction in antioxidant 
enzymes [43, 44]. Moreover, GSH is the most abundant thiol in 
mammalian tissue involved in the protection of the cell against damage 
from electrophiles free radicals and ROS formed during xenobiotic 
metabolism [45]. In the view of the aforementioned studies, the present 
results showed that oral administration of RIF produced a significant 
elevation in MDA levels associated with decreases in the levels of GSH. 
This could be attributed to the free radical formed either via the reaction 
of drug’s radicals with oxygen or through the interaction of superoxide 
radicals with hydrogen peroxide, which appeared to initiate lipid 
peroxidation in RIF-treated rats, suggesting that increased lipid 
peroxidation might be associated with cellular damage [17]. Also, the 
reduction found in GSH levels in RIF administered rats may be due to 
its increased utilization for enhancing the activities of GSH related 
enzymes GPX and GR [46]. Besides, previous studies stated that RIF 
alone or in combination with other anti-tuberculosis drugs caused a 
significant decrease in the hepatic antioxidant defense system and a 
significant increase in the MDA levels, probably due to excessive 
production of ROS [17].  
The present data indicated that treatment with MEAS and NAC or 
both resulted in significant decreases in MDA levels reflected by 
increases in GSH levels as compared to the RIF group. This could be 
due to MEAS and NAC exerted antioxidative and hepatoprotective 
activity, leading to reducing the hepatic oxidative stress and liver 
injury. In accordance with current results, Nandhakumar and 
Indumathi, [47] and Kalidindi et al. [48] reported that MEAS 
displayed significant inhibition of free radical scavenging activity 
including of α, α-diphenyl-β-picrylhydrazyl (DPPH) radical 
scavenging activity, NO scavenging activity, O2 scavenging activity 
and OH scavenging activity, which suggest that methanol extract has 
higher antioxidant activity due to a higher presence of phenolic and 
flavonodal constituents in the methanol extract. 
On the other hand, NAC generated from thiol-including amino acid 
cysteine, is an antioxidant and is a precursor for glutathione [49]. 
Due to the existence of thiol or sulfhydryl group (-SH), it could exert 
antioxidant action by stimulating intracellular GSH production. 
Therefore, it substitutes intracellular non-enzymatic antioxidant 
status like glutathione as well as enhances the activity of 
glutathione-s-transferase along with the up-regulation of other 
intracellular antioxidant enzyme level and thus it could be able to 
influence detoxification [50]. 
In the current investigations, RIF administrated to rats increased 
significantly the productions of hepatic inflammatory and apoptotic 
markers IL-6 and 8-OHdG complemented by a significant reduction 
in the hepatic IL-10 and B-cl2 compared with the normal control 
group. This result was in line with the observations reported in 
previous studies, which demonstrated that prolonged rifampicin 
treatment can induce inflammation and necrosis in the kidney cells 
and acute kidney injury [51]. Moreover, it has been shown that 
patients being given tuberculosis therapy are at greater risk of the 
immune reorganization inflammatory syndrome, an immediate 
inflammation and cytokine storm syndrome [52]. Furthermore, 
Nathiya et al. [53] confirmed that oral administration of 
antitubercular drugs enhances the expression of NF-κB and TNF-α, 
which could be due to the triggering of the extrinsic apoptotic 
pathway by the ROS. Interestingly, Over-production of ROS can 
cause liver inflammation and progressive liver inflammation 
promotes the production of interleukins 1 and 6, which act as 
fibroblast growth factors, by Kupffer cells [54]. 
The present findings have further shown that the administration of 
MEAS, NAC, or their combination to RIF treated rats markedly down-
regulated the levels of hepatic IL-6, 8-OHdG and up-regulated the hepatic 
levels of IL-10 and B-cl2. This could be attributed to their antioxidant and 
free radicals-scavenging activities, which confirmed their antioxidant 
effects in protecting cells against free radical and nuclear DNA damage 
related to RIF. The synergetic action of MEAS in enhancing the 
antioxidant status and reducing stress-mediated DNA damage explained 
depending on the fact that Annona squamosa contains flavonoids which 
might have scavenged the free radical offering hepatoprotection [11]. 
Moreover, Reliene and Schiestl [55] reported that NAC inhibited 
chemically-induced oxidative stresses and DNA damage through directly 
binding to chemical groups such as thiol group or DNA base in different 
models. Furthermore, Earlier studies have shown that NAC can exert a 
cytoprotective effect in different thiol-depleting cell death through 
binding to TNF-α and attenuate apoptosis via inhibiting the expression of 
some apoptosis-related genes [56, 57]. 
The present data of histological analysis revealed that RIF induced 
major impairments on liver tissue displayed by dilatation in portal 
veins with destruction in its walls; heavy leucocytic infiltration 
surrounded by necrotic lesions was observed. Also, Hepatic cells 
suffered severely from degeneration and karyolysis. This result 
coincides with the study of Abrar et al.[58] who observed varying 
degrees of damage in hepatic tissue after RIF treatment, as 
inflammation and dilation of central and portal vein with congestion. 
In addition to, swelling of hepatocytes, fatty degeneration, 
vacuolization and alterations were also observed. Moreover, 
leucocytic infiltration and necrotic lesions were abundant in the 
tissue. Besides, an increase in the number of kupffer cells and 
destruction in the whole architecture of the hepatic cells [33, 59]. In 
the present study, the administration of MEAS or NAC alone showed 
minor histopathological alterations in the liver tissue as evidenced 
by cytoplasmic degeneration, cellular necrosis, minimal 
inflammation and vacuolar degeneration [11, 40]. This observation 
was compensated by the co-administration of MEAS and NAC and 
restored the liver tissue to its normal architecture. 
Finally, the current histopathological observations confirmed 
biochemical findings, possibly through declining oxidative stress, 
DNA damage, and restoring homeostasis, indicating that co-
treatment of MEAS and NAC conferred a marked hepatoprotection 
against RIF induced hepatotoxicity in male rats. 
CONCLUSION 
The present findings demonstrated that the co-treatment of MEAS 
and NAC seems to be more effective and curative than alone 
treatment of MEAS or NAC and strongly compensated the liver 
damage induced by rifampicin via enhancing the antioxidant status 
and reducing lipid peroxidation, as well as reducing the 
inflammation and apoptosis. The present study suggested that the 
combination of MEAS and NAC treatment has a significant 
therapeutic benefit when administered with rifampicin treatment to 
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overcome the hepatotoxicity due to the anti-inflammatory and anti-
apoptotic effect of MEAS and NAC.  
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